Phenol

Mechanism of action

Phenol is a protoplasmic poison that acts through multiple mechanisms:

Protein denaturation: Phenol denatures cellular proteins by disrupting hydrogen bonds and hydrophobic interactions, leading to protein precipitation and loss of enzymatic function. This effect is concentration-dependent and irreversible at higher concentrations.

Membrane disruption: It penetrates and disrupts lipid bilayers of cell membranes, causing loss of membrane integrity and cell lysis. This property underlies its antiseptic and sclerosing effects.

Microbial action: At low concentrations, phenol acts as an antiseptic by disrupting bacterial cell walls and denaturing microbial proteins. It is bactericidal, fungicidal, and virucidal.

Neurolytic effect: At higher concentrations, phenol causes Wallerian degeneration of nerve fibers through direct axonal and myelin sheath destruction. This results in permanent or semi-permanent nerve blockade, making it useful for chronic pain management. Nerve regeneration may occur over months to years, but high concentrations can produce irreversible damage.

Sclerosing action: When injected into veins or hemorrhoidal tissue, phenol causes endothelial damage, thrombosis, and fibrosis, leading to vessel obliteration.

Indications

Phenol has multiple clinical applications across different medical specialties:

Sclerotherapy

• Internal hemorrhoids: Phenol in oil is injected submucosally to cause fibrosis and fixation of hemorrhoidal tissue
• Varicose veins: Occasionally used as an alternative sclerosing agent, though other agents are now preferred

Chemical neurolysis

• Chronic cancer pain: Intrathecal or epidural phenol for terminal cancer pain when oral analgesics fail
• Spasticity management: Phenol motor point blocks or nerve blocks for severe spasticity in cerebral palsy, stroke, or spinal cord injury
• Trigeminal neuralgia: Percutaneous glycerol or phenol injection into Meckel's cave
• Peripheral nerve blocks: Chemical neurolysis of specific nerves for localized chronic pain

Antiseptic and dermatologic uses

• Topical antiseptic: Low concentrations in throat lozenges, mouthwashes, and antiseptic solutions
• Chemical peels: High concentrations for deep chemical peeling of skin (Baker-Gordon peel)
• Nail ablation: Phenol application after nail avulsion to prevent ingrown toenail recurrence

Other uses

• Chemical matrixectomy: Destruction of nail matrix cells
• Wart removal: Caustic agent for resistant warts

Pharmacokinetics

Absorption: Phenol is rapidly absorbed through intact skin, mucous membranes, and wounds. Systemic absorption is the primary concern with topical use, especially over large surface areas. After injection for neurolysis, local absorption occurs with potential systemic distribution.

Distribution: Once absorbed, phenol distributes throughout body tissues. It crosses the blood-brain barrier and can reach toxic concentrations in the CNS with excessive absorption.

Metabolism: Phenol undergoes hepatic conjugation with sulfate and glucuronic acid to form phenyl sulfate and phenyl glucuronide. These metabolites are less toxic than the parent compound. Some oxidation to catechol and hydroquinone also occurs.

Excretion: Conjugated metabolites are excreted primarily in urine. Approximately 80% is eliminated within 24 hours. A small amount is exhaled unchanged through the lungs, which accounts for the characteristic odor.

Special considerations: Impaired hepatic function may reduce conjugation capacity and increase toxicity risk. Renal dysfunction may prolong elimination of conjugated metabolites. Systemic absorption increases with damaged skin, large application areas, and occlusive dressings.

Adverse effects

Local effects

• Tissue necrosis: Excessive tissue destruction at injection or application site
• Pain: Burning pain during application or injection
• Skin discoloration: Hypopigmentation or hyperpigmentation
• Scarring: Keloid formation or disfiguring scars, especially with chemical peels
• Nerve damage: Unintended motor weakness or sensory loss with improper neurolytic injection technique

Systemic toxicity

Systemic absorption of phenol can cause life-threatening toxicity:

Cardiovascular effects:

• Cardiac arrhythmias (ventricular tachycardia, ventricular fibrillation)
• Hypotension and cardiovascular collapse
• Myocardial depression

Central nervous system effects:

• CNS depression progressing from drowsiness to coma
• Seizures (with moderate toxicity)
• Tremors and muscle fasciculations
• Respiratory depression

Other systemic effects:

• Methemoglobinemia: Oxidation of hemoglobin iron
• Hemolysis: Direct red blood cell membrane damage
• Metabolic acidosis: Accumulation of acidic metabolites
• Renal toxicity: Acute tubular necrosis
• Hepatotoxicity: Centrilobular hepatic necrosis with large exposures

Signs of systemic toxicity: Symptoms typically appear within 30 minutes of significant absorption and include nausea, vomiting, pallor, sweating, tachycardia, irregular pulse, hypotension, dyspnea, cyanosis, and altered mental status.

Specific procedure-related effects

• Post-neurolysis dysesthesia: Burning or uncomfortable sensations after nerve blocks
• Bladder and bowel dysfunction: After intrathecal phenol for spasticity
• Motor weakness: Unintended motor block with neurolytic procedures

Contraindications and warnings

Absolute contraindications

• Known hypersensitivity to phenol
• Application to large body surface areas (risk of systemic toxicity)
• Use in infants and young children (increased absorption risk)
• Severely impaired hepatic function
• Pregnancy (unless benefit clearly outweighs risk)

Relative contraindications and warnings

• Renal impairment: Use with caution due to reduced excretion
• Cardiac disease: Increased risk of arrhythmias with systemic absorption
• G6PD deficiency: Increased risk of hemolysis
• Damaged or denuded skin: Markedly increased systemic absorption

Special precautions

Limit application area: Never apply to more than 25% body surface area. For chemical peels, limit to facial areas only and never perform full-face peels in a single session without appropriate monitoring.

Avoid mucous membranes: High absorption through mucous membranes increases toxicity risk.

Neurolysis technique: Chemical neurolysis should only be performed by experienced practitioners with fluoroscopic or ultrasound guidance to avoid unintended nerve damage or intravascular injection.

Emergency preparedness: Facilities performing phenol neurolysis or chemical peels must have resuscitation equipment and antiarrhythmic drugs immediately available.

Pregnancy and lactation: Phenol is pregnancy category C. Use only if potential benefits justify potential fetal risks. Avoid during breastfeeding due to unknown excretion in breast milk.

Monitoring: For procedures involving significant phenol use, continuous cardiac monitoring and pulse oximetry are recommended to detect early signs of systemic toxicity.

Drug interactions

Phenol has relatively few pharmacokinetic drug interactions, but several pharmacodynamic concerns exist:

Medications affecting cardiac conduction:

• Antiarrhythmic drugs (class I and III agents) may have additive cardiotoxic effects with systemic phenol absorption
• Beta-blockers may mask early tachycardic warning signs of phenol toxicity
• Drugs prolonging QT interval increase arrhythmia risk when combined with phenol

CNS depressants:

• Opioids, benzodiazepines, barbiturates, and general anesthetics may have additive CNS and respiratory depressant effects with absorbed phenol
• Use caution when phenol neurolysis is performed in sedated patients

Hepatically metabolized drugs:

• Phenol competes for hepatic conjugation pathways with other drugs undergoing glucuronidation or sulfation
• Acetaminophen, morphine, and other extensively conjugated drugs may have altered clearance

Oxidizing agents:

• Concomitant use with other methemoglobin-inducing agents (dapsone, nitrites, sulfonamides, local anesthetics) increases methemoglobinemia risk

Anticoagulants:

• Increased bleeding risk at neurolysis injection sites in patients on warfarin, DOACs, or antiplatelet agents
• Consider temporary discontinuation before elective neurolytic procedures per product labeling

Clinical note: Most interactions are theoretical concerns with systemic absorption. For properly performed localized procedures with appropriate phenol concentrations, clinically significant interactions are uncommon.

Clinical pearls

• Concentration matters: Low concentrations are used for sclerotherapy and antisepsis; intermediate concentrations for neurolysis; high concentrations for chemical peeling. Never confuse concentrations between indications.

• Alcohol neutralization: After chemical neurolysis, injecting absolute alcohol through the same needle may partially neutralize residual phenol and reduce post-procedure dysesthesia.

• Phenol vs. alcohol neurolysis: Phenol is less painful (nearly painless due to immediate local anesthetic effect) during injection compared to alcohol, which causes severe burning pain. Phenol causes less neuritis afterward. Phenol is preferred for motor nerve blocks; alcohol for sensory blocks in cancer pain.

• Baricity in intrathecal use: Phenol is hyperbaric in CSF. Patient positioning after intrathecal phenol determines which nerve roots are affected. Position the painful side down for 15-20 minutes post-injection.

• Test dose strategy: For neurolytic procedures, consider a diagnostic local anesthetic block first to predict the functional outcome of permanent neurolysis.

• Glycerin vehicle: Phenol is often prepared in glycerin for neurolysis (phenol in glycerin) to increase viscosity, reduce spread, and improve localization.

• Skin protection during peels: Apply petrolatum to perioral areas, nasolabial folds, and eyelids before chemical peeling to prevent unintended deep penetration in these sensitive areas.

• Systemic toxicity treatment: There is no specific antidote. Treatment is supportive: activated charcoal if recent oral ingestion, IV fluids, vasopressors for hypotension, antiarrhythmics for dysrhythmias, methylene blue for methemoglobinemia, and hemodialysis for severe toxicity.

• Odor as a clue: The characteristic sweet, acrid odor of phenol on a patient's breath or in exhaled air suggests systemic absorption and should prompt evaluation for toxicity.

• Duration of neurolysis: Phenol neurolysis typically lasts 3-6 months, occasionally up to 12 months. Repeated blocks can be performed as needed.

• Ultrasound vs. fluoroscopy: Modern practice favors ultrasound guidance for peripheral neurolytic blocks due to real-time visualization of needle placement and absence of radiation.

• Historical note: Phenol was the first antiseptic introduced into surgical practice by Joseph Lister in the 1860s, revolutionizing surgery by dramatically reducing infection rates.

Practice questions

Frequently asked questions

Conditions it is used for

Related drugs

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: C05BB05WHO ATC/DDD index: D08AE03

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.